Keynote Speakers

Robert Bazemore
President and Chief Executive Officer

Robert (Rob) Bazemore has served as President and Chief Executive Officer since September 2015. Prior to joining Epizyme, Rob served as Chief Operating Officer of Synageva, where he established the company's global commercial and medical organization to support the first product launch, and helped lead the broader transition to a sustainable commercial enterprise, through its acquisition in July 2015. With more than 25 years of experience across the life sciences industry, Rob held several senior leadership positions at Johnson & Johnson. This included his role as President of Janssen Biotech, where he led the successful launches of numerous products and indications, including the U.S. launches of the oncology therapies ZYTIGA® and IMBRUVICA®, as well as guiding the company's worldwide immunology portfolio strategy. Prior to Johnson & Johnson, he worked at Merck & Co., Inc. for 11 years in roles of increasing responsibility, including the launch of SINGULAIR® in the U.S.

Rob received a B.S. in Biochemistry from the University of Georgia. He currently sits on the Board of Directors of Ardelyx, Inc and Neon Therapeutics.

Andre Turenne
President and Chief Executive Officer
Voyager Therapeutics

Andre Turenne has been President and Chief Executive Officer of Voyager Therapeutics, a leader in gene therapy for severe neurological diseases, since July 2018. Andre is passionate about the power of collaboration in drug development.

Prior to joining Voyager, Andre was Senior Vice President and Global Head of Business Development & Licensing at Sanofi. In that role, he oversaw all partnering activities company-wide. During his twelve years at Genzyme and Sanofi, he also held leadership roles in strategy and commercial operations, established the alliance management function within Genzyme and served as country General Manager in Australia and New Zealand. Earlier in his career, Andre worked as a strategy consultant.

Andre holds an MBA from the Tuck School of Business at Dartmouth and a BA from Kalamazoo College.